We found that the SMSr deficiency can reverse GluCer accumulation-mediated NASH, liver fibrosis, and tumor formation and provided evidence that PE-PLC/SMSr deficiency–mediated PE accumulation is the key factor mediating these beneficial effects. Here, SAMD8 is linked to metabolic dysfunction-associated steatohepatitis.